AZNAZN

Buy more

Buy more on a dip to our buy price, which is under today's $184.

6 good· Earnings beat
3 to watch· Revenue slowing

$184.37−1.11 (−0.60%)

Price at 3:03 PM ET

After hours · opens in 17h 23m

Healthcare · Very large company

Tell me when AZN moves 5% in a day

The price we'd buy AZN at comes with a free account

It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources

From company filings, as of Nov 8
Yahoo Finance daily closes to Nov 9

Any one could move it to Keep

Next report

Shrinking
sales

Compared with the S&P 500

8 points
worse in one day
18 points
worse in five trading days

+6.5% in a yearsince Nov 10, 2025

Earnings report

The news behind our call

written Oct 30, 10:37 AM ETOct 30, 10:37 AM ET · 14 articles · 5 sources

AstraZeneca’s third-quarter revenue rose 7% to $16.21 billion.
AstraZeneca increased third-quarter profit while reaffirming full-year targets.
Healthcare is attracting broad participation.

What changed

From AZN via Nasdaq, Benzinga, Yahoo Finance and 1 more

AstraZeneca (LSE:AZN) Reaffirms guidance as Pipeline Strength keeps undervaluation in view
Tuesday
AstraZeneca (LSE:AZN) stock Fair Value Edges higher after mixed analyst target Changes
Tuesday
Analyst ratings shifted: 1 fewer buy, 1 more hold, 1 more sell
9 buy, 2 hold, 1 sell, against 10 buy, 1 hold, 0 sell the month before.
Analysts · Last month
AZN reported earnings
Earnings · Oct 30
AutoNation, Regeneron Pharmaceuticals, AstraZeneca and other big stocks moving higher on Friday
Oct 30
AstraZeneca Q3 profit rises; Pipeline Delivers 12 Positive Phase 3 Readouts; stock up
Oct 30
Stock market today: Dow Jones, S&P 500, Nasdaq 100 futures trade mixed as AMZN, INTC slide after Q3 earnings—DELL, LLY, AZN in focus (UPDATED)
Oct 30
AstraZeneca Q3 profit rises; Reconfirms FY26 revenue, Core EPS guidance at CER
Oct 30

Overview

In plain numbers

Revenue grew 7.3% from a year earlier, to $62.4B in the last twelve months.
It keeps 26 cents of every revenue dollar as operating profit, up from 8 cents in FY 2021.
It turned 16.4% of revenue into free cash flow: $10.2B in the last twelve months.
It owes $34.3B and holds $8.2B in cash and investments, so net debt is $26.2B.

Key figures

Revenue (TTM): $62.4B
Revenue growth, 1 year: +7.3%
Net income: $11.0B
EPS (diluted): $7.06
Gross margin: 81.8%
Operating margin: 25.8%

Return on equity: 22.6%
Return on capital: 17.1%
Debt / equity: 0.66
Current ratio: 1.01
Dividend yield: 1.75%
Buyback yield: 0.02%

Key facts

Company value: $289B
Price / last year's earnings: 24.6×
Today's range: 183.87185.85
Past year's range: 155.62208.62

Yesterday's close: $185.48
Swings vs the market: 0.2×smaller
Dividend yield: 1.75%$3.23 a year